Suraksha Diagnostic Ltd is scheduled to make its debut on the stock exchanges on December 6, following a successful IPO that concluded on December 3 with a subscription rate of 1.27 times.

The offering, valued at Rs 846 crore, received bids for 1.70 crore shares against the available 1.34 crore shares, with a price range set at Rs 420-441 per share.

The company offers a wide range of pathology, radiology, and medical consultation services through a central reference laboratory and eight satellite labs.

Analysts anticipate modest listing gains for the company, taking into account its mixed financial performance, including a setback in FY23. However, recent quarters have shown signs of recovery, as highlighted by Prathamesh Masdekar, Research Analyst at Stoxbox.